Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Population pharmacokinetics")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 826

  • Page / 34
Export

Selection :

  • and

Population pharmacokinetic model of PI-88, a heparanase inhibitorHUDACHEK, Susan F; ECKHARDT, S. Gail; HICKS, Barbara et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 4, pp 743-753, issn 0344-5704, 11 p.Article

Population pharmacokinetics of arbekacin in burn patientsJONG HYUN KIM; LAH, Hyon-Oh; YIM, Dong-Seok et al.European journal of clinical pharmacology. 2008, Vol 64, Num 6, pp 599-603, issn 0031-6970, 5 p.Article

Population pharmacokinetic modelling of BIBN 4096 BS, the first compound of the new class of calcitonin gene-related peptide receptor antagonistsTROCONIZ, Inaki F; WOLTERS, Jan-Markus; SCHAEFER, Hans Guenter et al.European journal of pharmaceutical sciences. 2004, Vol 22, Num 4, pp 287-295, issn 0928-0987, 9 p.Article

Population pharmacokinetics of itraconazole solution used as prophylaxis for febrile neutropeniaKANBAYASHI, Yuko; NOMURA, Kenichi; TANIWAKI, Masafumi et al.International journal of antimicrobial agents. 2008, Vol 31, Num 5, pp 452-457, issn 0924-8579, 6 p.Article

Population pharmacokinetics of PM00104 (Zalypsis®) in cancer patientsPEREZ-RUIXO, Carlos; VALENZUELA, Belén; FERNANDEZ TERUEL, Carlos et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 1, pp 15-24, issn 0344-5704, 10 p.Article

Bicompartmental kinetics of tobramycin analysed with a wide range of covariatesINCLAN, Gabriel; SUAREZ, Elena; CALVO, Rosario et al.International journal of antimicrobial agents. 2005, Vol 26, Num 4, pp 304-311, issn 0924-8579, 8 p.Article

Population pharmacokinetic study of methotrexate in patients with lymphoid malignancyFALTAOS, Demiana William; HULOT, Jean Sebastian; URIEN, Saïk et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, Num 5, pp 626-633, issn 0344-5704, 8 p.Article

Population pharmacokinetics of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine®) in cancer patientsKOLESAR, Jill; BRUNDAGE, Richard C; POMPLUN, Marcia et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 2, pp 393-400, issn 0344-5704, 8 p.Article

Population Pharmacokinetic Analysis during the First 2 Years of Life: An OverviewMARSOT, Amélie; BOULAMERY, Audrey; BRUGUEROLLE, Bernard et al.Clinical pharmacokinetics. 2012, Vol 51, Num 12, pp 787-798, issn 0312-5963, 12 p.Article

Fundamentals of Population Pharmacokinetic Modelling: Modelling and SoftwareKIANG, Tony K. L; SHERWIN, Catherine M. T; SPIGARELLI, Michael G et al.Clinical pharmacokinetics. 2012, Vol 51, Num 8, pp 515-525, issn 0312-5963, 11 p.Article

Reporting a Population Pharmacokinetic-Pharmacodynamic Study: A Journal's PerspectiveJAMSEN, Kris M; McLEAY, Sarah C; BARRAS, Michael A et al.Clinical pharmacokinetics. 2014, Vol 53, Num 2, pp 111-122, issn 0312-5963, 12 p.Article

Some considerations on the design of population pharmacokinetic studiesDUFFULL, Stephen; WATERHOUSE, Tim; ECCLESTON, John et al.Journal of pharmacokinetics and pharmacodynamics (Print). 2005, Vol 32, Num 3-4, pp 441-457, issn 1567-567X, 17 p.Article

Understanding the time course of pharmacological effect: a PKPD approachWRIGHT, Daniel F. B; WINTER, Helen R; DUFFULL, Stephen B et al.British journal of clinical pharmacology. 2011, Vol 71, Num 6, pp 815-823, issn 0306-5251, 9 p.Article

Population Pharmacokinetic Meta-Analysis of Vortioxetine in Healthy IndividualsAREBERG, Johan; PETERSEN, Kamilla B; CHEN, Grace et al.Basic & clinical pharmacology & toxicology (Print). 2014, Vol 115, Num 6, pp 552-559, issn 1742-7835, 8 p.Article

Fundamentals of Population Pharmacokinetic Modelling: Validation MethodsSHERWIN, Catherine M. T; KIANG, Tony K. L; SPIGARELLI, Michael G et al.Clinical pharmacokinetics. 2012, Vol 51, Num 9, pp 573-590, issn 0312-5963, 18 p.Article

Methods to Account for Inaccuracies in the Dosing History When Performing Population Pharmacokinetic AnalysisPAVAN KUMAR, Venkata V; DUFFULL, Stephen B.Pharmaceutical research. 2008, Vol 25, Num 12, pp 2740-2749, issn 0724-8741, 10 p.Article

Population pharmacokinetics of troxacitabine, a novel dioxolane nucleoside analogueLEE, Carlton K. K; ROWINSKY, Eric K; JING LI et al.Clinical cancer research. 2006, Vol 12, Num 7, pp 2158-2165, issn 1078-0432, 8 p., 1Article

The odds that clinically unrecognized poor or partial adherence confuses population pharmacokinetic/pharmacodynamic analysesVRIJENS, Bernard; GROSS, Robert; URQUHART, John et al.Basic & clinical pharmacology & toxicology (Print). 2005, Vol 96, Num 3, pp 225-227, issn 1742-7835, 3 p.Article

Population Pharmacokinetics of Therapeutic Monoclonal AntibodiesDIRKS, Nathanael L; MEIBOHM, Bernd.Clinical pharmacokinetics. 2010, Vol 49, Num 10, pp 633-659, issn 0312-5963, 27 p.Article

Edoxaban population pharmacokinetics and exposure-response analysis in patients with non-valvular atrial fibrillationYIN, Ophelia Q. P; TETSUYA, Kimura; MILLER, Raymond et al.European journal of clinical pharmacology. 2014, Vol 70, Num 11, pp 1339-1351, issn 0031-6970, 13 p.Article

Population pharmacokinetics of metformin in obese and non-obese patients with type 2 diabetes mellitusBARDIN, Christophe; NOBECOURT, Estelle; LARGER, Etienne et al.European journal of clinical pharmacology. 2012, Vol 68, Num 6, pp 961-968, issn 0031-6970, 8 p.Article

Population pharmacokinetics and pharmacogenetics of vincristine in paediatric patients treated for solid tumour diseasesGUILHAUMOU, Romain; SIMON, Nicolas; QUARANTA, Sylvie et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 5, pp 1191-1198, issn 0344-5704, 8 p.Article

Population pharmacokinetic analysis of ten phase II clinical trials of pemetrexed in cancer patientsLATZ, Jane E; CHAUDHARY, Ajai; GHOSH, Atalanta et al.Cancer chemotherapy and pharmacology. 2006, Vol 57, Num 4, pp 401-411, issn 0344-5704, 11 p.Article

Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysisSHERWIN, Catherine M. T; SVAHN, Sofia; VAN DER LINDEN, Antje et al.European journal of clinical pharmacology. 2009, Vol 65, Num 7, pp 705-713, issn 0031-6970, 9 p.Article

Population pharmacokinetics meta-analysis of plitidepsin (Aplidin®) in cancer subjectsNALDA-MOLINA, Ricardo; VALENZUELA, Belén; RAMON-LOPEZ, Amelia et al.Cancer chemotherapy and pharmacology. 2009, Vol 64, Num 1, pp 97-108, issn 0344-5704, 12 p.Article

  • Page / 34